Means and methods for counteracting myeloproliferative or lymphoproliferative disorders
The invention provides human AML-specific binding compounds that are able to bind a cell surface component of AML cells. Therapeutic uses of binding compounds against AML are also provided.
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
18.06.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides human AML-specific binding compounds that are able to bind a cell surface component of AML cells. Therapeutic uses of binding compounds against AML are also provided. |
---|---|
Bibliography: | Application Number: AU20140367398 |